Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of Glycyrrhizin in Early Vascular Lesions of Systemic Sclerosis
jRCTs031180366Recruiting
- Start
- Jan 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of glycyrrhizin in systemic sclerosis (SSc). Primary endpoint: Change in nailfold capillary density. Started Jan 2020; status: recruiting.
02
Drugs
glycyrrhizin
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on jRCTs031180366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180366.